Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.510
+0.050 (1.45%)
At close: Mar 9, 2026, 4:00 PM EDT
3.480
-0.030 (-0.85%)
After-hours: Mar 9, 2026, 6:03 PM EDT

Recursion Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Market Capitalization
1,8542,1292,6662,1361,4612,895
Upgrade
Market Cap Growth
-54.58%-20.16%24.83%46.15%-49.52%-
Upgrade
Enterprise Value
1,1891,5512,3291,8001,0592,317
Upgrade
Last Close Price
3.514.096.769.867.7117.13
Upgrade
PS Ratio
24.8328.5045.3247.9236.68284.42
Upgrade
PB Ratio
1.641.882.584.613.015.33
Upgrade
P/TBV Ratio
2.813.234.855.703.025.35
Upgrade
EV/Sales Ratio
15.9220.7739.5940.3826.58227.62
Upgrade
Debt / Equity Ratio
0.070.070.110.110.110.00
Upgrade
Net Debt / Equity Ratio
-0.59-0.59-0.47-0.74-1.03-0.95
Upgrade
Net Debt / EBITDA Ratio
1.181.181.101.052.132.96
Upgrade
Net Debt / FCF Ratio
1.761.761.301.144.142.60
Upgrade
Asset Turnover
0.050.050.060.070.060.02
Upgrade
Quick Ratio
5.205.203.434.245.5111.27
Upgrade
Current Ratio
5.505.503.814.705.6811.46
Upgrade
Return on Equity (ROE)
-59.54%-59.54%-61.90%-69.12%-46.56%-47.51%
Upgrade
Return on Assets (ROA)
-27.72%-27.72%-28.48%-32.29%-23.42%-25.14%
Upgrade
Return on Capital Employed (ROCE)
-48.90%-48.90%-38.00%-62.50%-40.90%-32.40%
Upgrade
Earnings Yield
-34.78%-30.29%-17.39%-15.36%-16.39%-6.44%
Upgrade
FCF Yield
-20.40%-17.77%-13.98%-14.03%-8.25%-6.85%
Upgrade
Buyback Yield / Dilution
-63.18%-63.18%-31.92%-18.41%-40.04%-475.48%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.